Skip to main content
. 2021 Mar 2;114(5):352–363. doi: 10.1016/j.acvd.2021.01.003

Table 2.

Paraclinical features of the study population, overall and according to vital status.

Variable N Overall (N = 2878) Alive (n = 2503) Died in hospital (n = 360) P
Laboratory values
 Haemoglobin (g/dL) 2835 13.1 ± 2.0 13.2 ± 1.9 12.7 ± 2.2 < 0.001
 Leucocytes (g/L) 2827 7.3 ± 5.1 7.1 ± 4.6 9.0 ± 7.8 < 0.001
 Lymphocytes (g/L) 2785 1.3 ± 3.5 1.3 ± 2.7 1.6 ± 6.7 0.07
 Platelets (g/L) 2807 220 ± 99 223 ± 99 203 ± 101 0.001
 GFR (mL/min/m2) 2829 81.6 ± 29.5 84.6 ± 28.1 61.8 ± 31.3 < 0.001
 Aspartate aminotransferase (IU/L) 2608 53.7 ± 69.0 50.9 ± 62.5 72.8 ± 102 < 0.001
 Total bilirubin (mg/L) 2423 10.9 ± 13.4 10.6 ± 13.4 12.2 ± 10.2 0.04
 Gamma glutamyl transferase (IU/L) 2301 92 ± 31 90 ± 127 106 ± 156 0.04
 Alkaline phosphatase (IU/L) 2366 90 ± 119 88 ± 120 108 ± 108 0.003
 Phosphoraemia (mmol/L) 1077 1.0 ± 0.3 0.97 ± 0.3 1.1 ± 0.4 < 0.001
 Corrected serum calcium (mmol/L) 1258 2.4 ± 0.2 2.4 (0.2) 2.5 (0.3) 0.003
 Albumin (g/L) 1642 31.8 ± 6.5 32.1 ± 6.5 29.8 ± 6.2 < 0.001
 C-reactive protein (mg/L) 2758 90.3 ± 77.1 85.7 ± 74.3 121.0 ± 85.9 < 0.001
 Fibrinogen (g/L) 1379 6.0 ± 1.7 6.0 ± 1.7 6.0 ± 1.5 0.91
 Prothrombin rate (%) 2215 85.0 ± 18.1 85.9 ± 17.6 78.4 ± 20.3 < 0.001
 D-dimer (μg/L) 1156 1644 ± 3633 1481 ± 2407 3025 ± 8624 0.051
 pH 2006 7.5 ± 0.1 7.5 ± 0.1 7.4 ± 0.1 < 0.001
 Lactates (mmol/L) 1756 1.4 ± 1.0 1.4 ± 0.8 1.9 ± 1.6 < 0.001
 Elevated BNP or NT-pro-BNPa 1778 943 (53.0) 702 (47.2) 234 (83.6) < 0.001
 Troponin elevationb 1763 572 (32.4) 442 (28.8) 127 (58.5) < 0.001
 qSOFA score ≥ 2 2109 1298 (61.5) 1094 (59.8) 196 (73.4) < 0.001
 Sepsis-induced coagulopathy score > 1 1672 1135 (67.9) 969 (66.2) 162 (80.2) < 0.001
Electrocardiogram
 Heart rate (beats/min) 2624 86.6 ± 17.9 86.5 ± 17.6 87.8 ± 20.2 0.16
 Complete bundle-branch block 2121 164 (7.7) 122 (6.5) 42 (17.4) < 0.001
 Non-sinus rhythm 2312 260 (11.2) 196 (9.7) 64 (23.3) < 0.001
 Corrected QT-segment (ms) 1162 435 ± 51 433 ± 50 458 ± 55 < 0.001
Chest computed tomography
 Parenchymal involvement 2247 < 0.001
  Mild (< 30) 953 (42.4) 874 (43.9) 77 (31.2)
  Moderate (30 − 50) 864 (38.5) 764 (38.4) 96 (38.9)
  Severe (> 50) 430 (19.1) 353 (17.7) 74 (30.0)

Data are expressed as number (%) or mean ± SD. Fifteen patients with unknown final status were excluded from the analysis. BNP: B-type natriuretic peptide; GFR: glomerular filtration rate; NT − pro-BNP: N-terminal pro-B-type natriuretic peptide; qSOFA: quick Sequential Organ Failure Assessment.

a

BNP > 50 pg/mL or NT-pro-BNP > 300 pg/mL.

b

Above each centre threshold.